Dr. Ogunseinde noted, “Developed with SI-BONE in Longview, Texas, the posteromedial technique is designed to transform the treatment of SI joint dysfunction. Its simplicity enables physicians to treat patients using a minimally invasive approach, enhancing both accessibility and efficiency in the OR.”
About SI-BONE, Inc. SI-BONE (NASDAQ: SIBN) is a leading provider of technology for the surgical treatment of sacropelvic disorders. Since 2009, SI-BONE has been at the forefront of minimally invasive SI joint surgery, supporting over 3,900 physicians in performing more than 100,000 sacropelvic procedures worldwide. SI-BONE’s technologies are backed by robust clinical evidence, including two randomized controlled trials and over 135 peerreviewed studies. Building on its expertise in minimally invasive SI joint fusion, SI-BONE has expanded into adjacent areas such as adult deformity, spinopelvic fixation, and pelvic trauma. For more information, visit www.si-bone.com.
